The Top Line cover image

Biopharma layoffs aren't letting up

The Top Line

00:00

Impact of Federal Cuts on Biopharma Layoffs

This chapter examines the ongoing layoffs within the biopharma sector, linking them to federal cuts and regulations that heighten industry uncertainty. It features examples from Icon Therapeutics and 10X Genomics, discussing the potential long-term impact of these challenges.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app